iPad Mini in China: Apple Taking Cellular iPad 4 and Mini to China

iPad Mini in China: After selling more than 2 million iPhone 5’s in China last weekend, it is easy to see why Apple Inc. (NASDAQ:AAPL) would be interested in rolling out other products in this country.

Apple Inc (AAPL)Apple Inc. (NASDAQ:AAPL) Press Info

According to various sources, including AppleInsider, the tech giant has “acquired the network licenses needed to start sales of its cellular-enabled iPad mini and fourth-generation iPad.”

Much like the iPhone 5, these tablets will be available on the China Telecom and China Unicom networks. Left out of the equation once again is China Mobile and its 700 million subscribers.

On December 7, 2012, Wi-Fi only versions of the popular fourth generation iPad and iPad Mini were released to the public in China.

At this point, Apple Inc. (NASDAQ:AAPL) has yet to release any sales figures for the tablets. Whether or not the product is selling as well as the iPhone 5 has yet to be seen, however, the numbers are not expected to be quite that high.

A recent article in the China Post discusses how the addition of the iPad and Nexus 7 will help grow the market.

Below is an inside look at a recent reported compiled by research firm International Data Corp. (IDC):

Appetite for smaller tablets is irrefutable and 2013 will see intensified competition in the smaller tablet space, during which Samsung Electronics Co.’s current dominance is set to be tested, particularly by Apple’s iPad mini.

The arrival of the iPad mini at a comparable price to the United States and a 100 Malaysian Ringgits (US$33) price drop for the Nexus 7 represents the beginnings of a more competitive 7-inch tablet space in Malaysia.

Consumers in both China and Malaysia are keeping a close eye on the tablet market, with most expecting to see a shift towards smaller devices in 2013.

Check back here for more updates on iPad Mini in China.

View some of our previous coverage on the Apple Inc. (NASDAQ:AAPL) tablets here:

Apple Inc. iPad Mini On Pace to Outsell Big Brother

An Interesting Take on Apple Inc. iPad vs. Microsoft Corporation Surface Tablet

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!